Evidence
Clin Geriatr Med. 2023 Feb;39(1):91-107. doi: 10.1016/j.cger.2022.07.005. Epub 2022 Oct 18.
ABSTRACT
Dementias encompass a range of debilitating neurologic conditions. Here, we summarize the neuropathology of common forms of dementia, focusing on Alzheimer disease (AD) and related dementias. AD is part of a spectrum of neurodegenerative diseases that consists of various protein inclusions (ie, proteinopathies) but other brain abnormalities are also related to dementia. Beta-amyloid and tau aggregates are hallmarks of AD. Other tissue substrates include Lewy bodies, TDP-43 inclusions, vascular brain lesions, and mixed pathologies. This review highlights the complexity of neurodegenerative and other disease substrates and summarizes topography of these lesions and concepts of mixed brain pathologies, resistance, and resilience.
PMID:36404035 | DOI:10.1016/j.cger.2022.07.005
Add to Google Keep
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Neuropathology of the Common Forms of Dementia
🌐 90 Days
VR Related Evidence Matrix
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia
- Ageing-Related Neurodegeneration and Cognitive Decline
- TDP-43 and Alzheimer's Disease Pathology in the Brain of a Harbor Porpoise Exposed to the Cyanobacterial Toxin BMAA
- The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Pathological Markers of Alzheimer's Disease and Related Dementia in the Rhesus Macaque Amygdala
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Alzheimer's disease biomarker analysis using targeted mass spectrometry
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
- Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies
- Identifying Mixed Dementia With Lewy Bodies and Alzheimer Disease Using Multitracer PET Imaging: A Case Study
- Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia
- Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- Understanding age-related pathologic changes in TDP-43 functions and their consequence on RNA splicing and signalling in health and disease
- Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
- Is Alzheimer disease a disease?
- Porphyromonas gingivalis, neuroinflammation and Alzheimer's disease
- Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias
- Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions
- Innate immune activation in neurodegenerative diseases
- Associations of sleep disorders with all-cause MCI/dementia and different types of dementia - clinical evidence, potential pathomechanisms and treatment options: A narrative review
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Neuropathologic changes at age 90+ related to sleep duration 19 to 40 years earlier: The 90+ Study
- Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis
- Disentangling tau: One protein, many therapeutic approaches
- The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review
- Unraveling the Dual Role of ADAM10: Bridging the Gap between Cancer and Alzheimer's Disease
- Interplay between the glymphatic system and neurotoxic proteins in Parkinson's disease and related disorders: current knowledge and future directions
- Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review
- Impact of Sleep Disorders and Disturbed Sleep on Brain Health: A Scientific Statement From the American Heart Association
- Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
- Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis
- Postacute Care and Long-term Care for LGBTQ+ Older Adults
- A novel Zebrafish model of Alzheimer's disease by Aluminium chloride; involving nitro-oxidative stress, neuroinflammation and cholinergic pathway
- 99mTc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder
- Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
- Point prevalence of epilepsy in dementia: A "real-world" estimate
- Are age-related neurodegenerative diseases caused by a lack of the diet-derived compound ergothioneine?
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases
- Brain structural indicators of beta-amyloid neuropathology
- Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks
- Ranking and filtering of neuropathology features in the machine learning evaluation of dementia studies
Evidence Blueprint
Neuropathology of the Common Forms of Dementia
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Neuropathology of the Common Forms of Dementia
🌐 365 Days
VR Related Evidence Matrix
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Polypathologic associations with grey matter atrophy in neurodegenerative disease
- Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia
- Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
- Pathophysiology of dementia
- Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia
- Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss
- Ageing-Related Neurodegeneration and Cognitive Decline
- Relative contributions of mixed pathologies to cognitive and functional symptoms in brain donors exposed to repetitive head impacts
- Insights into the Pathological Basis of Dementia from Population Based Neuropathology Studies
- Elucidating distinct molecular signatures of Lewy body dementias
- TDP-43 and Alzheimer's Disease Pathology in the Brain of a Harbor Porpoise Exposed to the Cyanobacterial Toxin BMAA
- The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Disrupting pathologic phase transitions in neurodegeneration
- Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases
- Pathological Markers of Alzheimer's Disease and Related Dementia in the Rhesus Macaque Amygdala
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia: Dementia Series
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Dementia with Lewy bodies: state of the art and perspectives for the clinician
- Alzheimer's disease biomarker analysis using targeted mass spectrometry
- Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease
- A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
- Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies
- Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia
- Age-related hearing loss and dementia-related neuropathology: An analysis of the United Kingdom brains for dementia research cohort
- Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes
- Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease
- Dem-Aging: autophagy-related pathologies and the "two faces of dementia"
- Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
- Nuclear Expression of TDP-43 Is Linked with Morphology and Ubiquitylation of Cytoplasmic Aggregates in Amyotrophic Lateral Sclerosis
- Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics
- Identifying Mixed Dementia With Lewy Bodies and Alzheimer Disease Using Multitracer PET Imaging: A Case Study
- Emerging Nanotechnology for the Treatment of Alzheimer's Disease
- Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort
- Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia
- Neuropathology of Alzheimer's Disease
- The correlation between neuropathology levels and cognitive performance in centenarians
- The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
- Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
- Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia